Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Corvus Pharmaceuticals, Inc. (CRVS)  
$2.03 0.07 (3.57%) as of 4:30 Thu 5/9


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 28,040,000
Market Cap: 56.92(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.08 - $3.86
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 12.1
Insider 6 Months    : 12.1
Insider 3/6 Months : 24.4
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Corvus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of immune modulator product candidates to treat solid cancers, T-cell lymphomas, autoimmune diseases and infectious diseases. Co.'s lead product candidate is mupadolimab, a humanized monoclonal antibody that is designed to react with a specific site on CD73. Co.'s next product candidate, CPI-818, is a selective, covalent inhibitor of ITK and is in a multi-center Phase 1/1b clinical trial in patients with various malignant T-cell lymphomas. Co.'s third product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 597,634 597,634 607,634 782,524
Total Buy Value $1,034,624 $1,034,624 $1,059,124 $1,196,645
Total People Bought 2 2 3 4
Total Buy Transactions 2 2 3 14
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-09 2023-11-08 2023-05-10 2022-05-10

   
Records found: 112
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Thompson Peter A Director   –       •       •   2021-02-17 4 B $3.50 $4,499,999 I/I 1,285,714 8,053,298 2.25 -23%     
   Miller Richard A Md President and CEO   •       •      –    2021-02-17 4 B $3.50 $350,000 I/I 100,000 1,278,515 2.66 -23%     
   Novo A/s 10% Owner   –       –       •   2020-07-08 4 S $5.37 $3,985,166 D/D (741,440) 1,389,498 22%     
   Novo A/s 10% Owner   –       –       •   2020-07-07 4 S $5.25 $4,183,381 D/D (796,622) 2,130,938 17%     
   Novo A/s 10% Owner   –       –       •   2020-04-30 3 IO $0.00 $0 D/D 0 2,927,560 56%     
   Miller Richard A Md President and CEO   •       •      –    2019-11-13 4 B $3.00 $44,240 I/I 14,736 1,178,515 2.66     -
   Miller Richard A Md President and CEO   •       •      –    2019-11-12 4 B $2.90 $789 I/I 272 1,163,779 2.58     -
   Miller Richard A Md President and CEO   •       •      –    2019-08-07 4 B $3.54 $8,850 I/I 2,500 1,163,507 2.58     -
   Thompson Peter A Director   –       •       •   2019-08-06 4 B $3.51 $500,723 I/I 142,656 6,767,584 2.25     -
   Miller Richard A Md President and CEO   •       •      –    2019-08-06 4 B $3.58 $17,875 I/I 5,000 1,161,007 2.58     -
   Orbimed Capital Gp V Llc Director   –       •       •   2019-08-06 4 B $3.51 $500,723 I/I 142,656 6,767,584 2.25     -
   Novo A/s 10% Owner   –       –       •   2019-07-25 4 S $4.00 $5,600,000 D/D (1,400,000) 2,927,560     -
   Novo A/s 10% Owner   –       –       •   2019-07-24 4 S $5.01 $266,711 D/D (53,240) 4,327,560     -
   Novo A/s 10% Owner   –       –       •   2019-07-23 4 S $5.32 $211,134 D/D (39,716) 4,380,800     -
   Thompson Peter A Director   –       •       •   2019-07-01 4 B $3.91 $231,640 I/I 59,243 6,624,928 2.25     -
   Orbimed Capital Gp V Llc Director   –       •       •   2019-07-01 4 B $3.91 $231,640 I/I 59,243 6,624,928 2.25     -
   Thompson Peter A Director   –       •       •   2019-06-28 4 B $3.72 $2,102,462 I/I 565,178 6,565,685 2.25     -
   Orbimed Capital Gp V Llc Director   –       •       •   2019-06-28 4 B $3.72 $2,102,462 I/I 565,178 6,565,685 2.25     -
   Thompson Peter A Director   –       •       •   2019-06-27 4 B $3.34 $109,963 I/I 32,923 6,000,507 2.25     -
   Orbimed Capital Gp V Llc Director   –       •       •   2019-06-27 4 B $3.34 $109,963 I/I 32,923 6,000,507 2.25     -
   Miller Richard A Md President and CEO   •       •      –    2019-06-14 4 B $3.40 $39,666 I/I 11,657 1,156,007 2.66     -
   Miller Richard A Md President and CEO   •       •      –    2019-06-13 4 B $3.52 $1,207 I/I 343 1,144,350 2.58     -
   Miller Richard A Md President and CEO   •       •      –    2019-06-11 4 B $3.67 $22,020 I/I 6,000 1,144,007 2.58     -
   Miller Richard A Md President and CEO   •       •      –    2019-06-07 4 B $3.37 $31,019 I/I 9,212 1,138,007 2.66     -
   Lea Leiv Chief Financial Officer   •       –      –    2019-06-07 4 B $3.38 $33,800 I/I 10,000 50,200 1.99     -
  112 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us